Related Experiment Video

Updated: Jan 10, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K

Combinatorial BCL2/BCL2L1 expression predicts clinical response to ruxolitinib in myelofibrosis

Giacomo Coltro1,2, Viola Videschi3, Francesca Gesullo1,2

  • 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Biomarker Research
|November 25, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BCL-2BCL-2 family proteinsBCL-xLCombinatorial scoreMCL-1MyelofibrosisResponse predictionRuxolitinib

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.6K
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.8K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K